Beijing Key Laboratory of Diabetes Prevention and Research, Endocrinology Center, Luhe Hospital, Capital Medical University, Beijing 101149, China.
Biomed Res Int. 2019 Jul 17;2019:3814687. doi: 10.1155/2019/3814687. eCollection 2019.
Angiopoietin-like proteins (Angptls) play critical roles in biological processes, primarily in lipid metabolism. The functional state of the thyroid has a profound influence on metabolism in the human body. Therefore, the aim of this study was to investigate possible changes in serum Angptl3, 4, and 8 levels in hypothyroid patients.
The study included 29 patients with clinical hypothyroidism, 30 patients with subclinical hypothyroidism, and 29 healthy subjects. Baseline clinical indices, including serum thyroid function tests, were recorded and serum Angptl3, 4, and 8 levels were measured across the three groups.
Serum Angptl3 and 8 levels were significantly higher in the hypothyroid groups compared to the control group ( < 0.05). There were no differences in Angptl4 levels among the three groups ( > 0.05). Positive correlations were identified between Angptl3 and high-density lipoprotein cholesterol (r = 0.431, < 0.001), and there was a negative correlation between Angptl3 and total tri-iodothyronine (TT3) (r = -0.220, = 0.047) and free tri-iodothyronine (r = - 0.279, = 0.013) levels. Angptl8 was positively correlated with triglyceride (r = 0.267, = 0.012) and cholesterol levels (r= 0.235, = 0.028) but was negatively correlated with tri-iodothyronine (r = -0.24, = 0.031). Furthermore, we used receiver operating characteristic curve analysis to evaluate the diagnostic performance of Angptl3 and 8 in discriminating thyroid dysfunction. The area under curve for detecting thyroid dysfunction based on Angptl3 and Angptl8 was 0.763.
Our data show that serum Angptl3 and 8 levels are increased in clinical and subclinical hypothyroid patients and that Angptl3 and 8 may serve as possible biomarkers of hypothyroid disease.
血管生成素样蛋白(Angptls)在生物过程中发挥着关键作用,主要参与脂质代谢。甲状腺的功能状态对人体代谢有深远影响。因此,本研究旨在探讨甲状腺功能减退症患者血清 Angptl3、4 和 8 水平的可能变化。
本研究纳入了 29 例临床甲状腺功能减退症患者、30 例亚临床甲状腺功能减退症患者和 29 例健康对照者。记录了各组的基线临床指标,包括血清甲状腺功能检查,并测量了血清 Angptl3、4 和 8 水平。
甲状腺功能减退症组的血清 Angptl3 和 8 水平明显高于对照组(<0.05)。三组之间 Angptl4 水平无差异(>0.05)。Angptl3 与高密度脂蛋白胆固醇呈正相关(r=0.431,<0.001),与总三碘甲状腺原氨酸(TT3)(r=-0.220,=0.047)和游离三碘甲状腺原氨酸(r=-0.279,=0.013)呈负相关。Angptl8 与甘油三酯(r=0.267,=0.012)和胆固醇水平呈正相关(r=0.235,=0.028),与三碘甲状腺原氨酸呈负相关(r=-0.24,=0.031)。此外,我们使用受试者工作特征曲线分析评估了 Angptl3 和 8 对甲状腺功能障碍的诊断性能。基于 Angptl3 和 Angptl8 检测甲状腺功能障碍的曲线下面积为 0.763。
我们的数据表明,临床和亚临床甲状腺功能减退症患者的血清 Angptl3 和 8 水平升高,Angptl3 和 8 可能是甲状腺功能减退症的潜在生物标志物。